An erythrocyte membrane-modified biomimetic synergistic nanosystem for cancer anti-vascular therapy and initial efficacy monitoring-Reference-Cited by-同舟云学术

An erythrocyte membrane-modified biomimetic synergistic nanosystem for cancer anti-vascular therapy and initial efficacy monitoring

Published:2023 Issue:30 Volume:11 Page:7160-7168
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Zhang Jieying¹,Li Fang¹,Su Lili²,Hu Qian¹,Li Jianfeng²,Zhu Xingjun¹^ORCID

Affiliation:

1. School of Physical Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, 201210, P. R. China

2. Gene Editing Center, School of Life Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, 201210, P. R. China

Abstract

In this work, a biomimetic nanosystem consisting of erythrocyte membrane modified nanocomposites is developed for synergistic anti-vascular cancer therapy and initial efficacy monitoring.

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

ShanghaiTech University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2023/TB/D3TB00807J

Reference45 articles.

1. Small GTPase R-Ras Regulates Integrity and Functionality of Tumor Blood Vessels

2. Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of Nanoparticles

3. Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases

4. Repurposing Erythrocytes as a “Photoactivatable Bomb”: A General Strategy for Site‐Specific Drug Release in Blood Vessels

5. Drug Insight: vascular disrupting agents and angiogenesis—novel approaches for drug delivery

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic Cell Membrane‐Coated Nanoparticles for Cancer Theranostics;ChemMedChem;2024-09-12